BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19688977)

  • 21. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants.
    Beà S; Ribas M; Hernández JM; Bosch F; Pinyol M; Hernández L; García JL; Flores T; González M; López-Guillermo A; Piris MA; Cardesa A; Montserrat E; Miró R; Campo E
    Blood; 1999 Jun; 93(12):4365-74. PubMed ID: 10361135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PPM1D is a potential therapeutic target in ovarian clear cell carcinomas.
    Tan DS; Lambros MB; Rayter S; Natrajan R; Vatcheva R; Gao Q; Marchiò C; Geyer FC; Savage K; Parry S; Fenwick K; Tamber N; Mackay A; Dexter T; Jameson C; McCluggage WG; Williams A; Graham A; Faratian D; El-Bahrawy M; Paige AJ; Gabra H; Gore ME; Zvelebil M; Lord CJ; Kaye SB; Ashworth A; Reis-Filho JS
    Clin Cancer Res; 2009 Apr; 15(7):2269-80. PubMed ID: 19293255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
    Evans MF; McDicken IW; Herrington CS
    J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA.
    López V; González-Peramato P; Suela J; Serrano A; Algaba F; Cigudosa JC; Vidal A; Bellmunt J; Heredero O; Sánchez-Carbayo M
    J Transl Med; 2013 Aug; 11():182. PubMed ID: 23914742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization.
    Nakao K; Mehta KR; Fridlyand J; Moore DH; Jain AN; Lafuente A; Wiencke JW; Terdiman JP; Waldman FM
    Carcinogenesis; 2004 Aug; 25(8):1345-57. PubMed ID: 15001537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival.
    Weiss MM; Kuipers EJ; Postma C; Snijders AM; Pinkel D; Meuwissen SG; Albertson D; Meijer GA
    Cell Oncol; 2004; 26(5-6):307-17. PubMed ID: 15623941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Genomic Alterations of Perineural Invasion in Patients with Stage II Colorectal Cancer.
    Su H; Chang C; Hao J; Xu X; Bao M; Luo S; Zhao C; Liu Q; Wang X; Zhou Z; Zhou H
    Onco Targets Ther; 2020; 13():11571-11582. PubMed ID: 33204110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization.
    Korn WM; Yasutake T; Kuo WL; Warren RS; Collins C; Tomita M; Gray J; Waldman FM
    Genes Chromosomes Cancer; 1999 Jun; 25(2):82-90. PubMed ID: 10337990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progressive genetic alterations of adenoid cystic carcinoma with high-grade transformation.
    Seethala RR; Cieply K; Barnes EL; Dacic S
    Arch Pathol Lab Med; 2011 Jan; 135(1):123-30. PubMed ID: 21204718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification.
    Courjal F; Theillet C
    Cancer Res; 1997 Oct; 57(19):4368-77. PubMed ID: 9331100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.
    Han W; Han MR; Kang JJ; Bae JY; Lee JH; Bae YJ; Lee JE; Shin HJ; Hwang KT; Hwang SE; Kim SW; Noh DY
    BMC Cancer; 2006 Apr; 6():92. PubMed ID: 16608533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a recurrent microdeletion at 17q23.1q23.2 flanked by segmental duplications associated with heart defects and limb abnormalities.
    Ballif BC; Theisen A; Rosenfeld JA; Traylor RN; Gastier-Foster J; Thrush DL; Astbury C; Bartholomew D; McBride KL; Pyatt RE; Shane K; Smith WE; Banks V; Gallentine WB; Brock P; Rudd MK; Adam MP; Keene JA; Phillips JA; Pfotenhauer JP; Gowans GC; Stankiewicz P; Bejjani BA; Shaffer LG
    Am J Hum Genet; 2010 Mar; 86(3):454-61. PubMed ID: 20206336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis.
    Zhang LH; Qin LX; Ma ZC; Ye SL; Liu YK; Ye QH; Wu X; Huang W; Tang ZY
    J Cancer Res Clin Oncol; 2003 May; 129(5):279-86. PubMed ID: 12734753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes.
    Loo LW; Grove DI; Williams EM; Neal CL; Cousens LA; Schubert EL; Holcomb IN; Massa HF; Glogovac J; Li CI; Malone KE; Daling JR; Delrow JJ; Trask BJ; Hsu L; Porter PL
    Cancer Res; 2004 Dec; 64(23):8541-9. PubMed ID: 15574760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification.
    Orsetti B; Courjal F; Cuny M; Rodriguez C; Theillet C
    Oncogene; 1999 Nov; 18(46):6262-70. PubMed ID: 10597224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas.
    Kuo KT; Guan B; Feng Y; Mao TL; Chen X; Jinawath N; Wang Y; Kurman RJ; Shih IeM; Wang TL
    Cancer Res; 2009 May; 69(9):4036-42. PubMed ID: 19383911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma.
    Hirata Y; Murai N; Yanaihara N; Saito M; Saito M; Urashima M; Murakami Y; Matsufuji S; Okamoto A
    BMC Cancer; 2014 Nov; 14():799. PubMed ID: 25366985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage.
    Partheen K; Levan K; Osterberg L; Helou K; Horvath G
    Genes Chromosomes Cancer; 2004 Aug; 40(4):342-8. PubMed ID: 15188458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative genomic hybridization analysis identifies gains of 1p35 approximately p36 and chromosome 19 in osteosarcoma.
    Zielenska M; Bayani J; Pandita A; Toledo S; Marrano P; Andrade J; Petrilli A; Thorner P; Sorensen P; Squire JA
    Cancer Genet Cytogenet; 2001 Oct; 130(1):14-21. PubMed ID: 11672768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma.
    Leung TH; Wong N; Lai PB; Chan A; To KF; Liew CT; Lau WY; Johnson PJ
    Mod Pathol; 2002 Nov; 15(11):1213-20. PubMed ID: 12429801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.